ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,772Medicare Part D Prescriptions Filled, Including Refills

Rank: 38 out of 229

$507K Total Retail Price of All Prescriptions

Rank: 48 out of 229

338 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Mexico
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 338 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

19% of this provider’s 338 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 6,963 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Mexico
LISINOPRIL 432 294 1 2
METFORMIN HCL 397 299 2 6
LEVOTHYROXINE SODIUM 313 213 3 1
HYDROCODONE-ACETAMINOPHEN 270 165 S3 4 7
OMEPRAZOLE 239 152 5 4
LOVASTATIN 232 151 6 11
AMLODIPINE BESYLATE 230 187 7 5
AZITHROMYCIN 225 152 8 53
PREDNISONE 216 154 9 35
WARFARIN SODIUM 213 176 10 17
FUROSEMIDE 207 151 11 8
SIMVASTATIN 204 176 12 3
CEFDINIR 193 159 13 187
CARVEDILOL 191 145 14 31
ATORVASTATIN CALCIUM 169 120 15 15
ZOLPIDEM TARTRATE 139 81 16 20
CEFPROZIL 133 69 17 209
GABAPENTIN 118 70 18 10
METOPROLOL SUCCINATE 117 64 19 16
SERTRALINE HCL 115 92 20 22
TERAZOSIN HCL 114 99 21 74
GLYBURIDE 111 86 R 22 57
RANITIDINE HCL 110 46 23 32
FAMOTIDINE 109 77 24 84
PRAVASTATIN SODIUM 108 73 25 25
MECLIZINE HCL 103 84 26 131
POTASSIUM CHLORIDE 101 69 27 18
NEXIUM 97 89 28 48
HYDROCHLOROTHIAZIDE 94 65 29 9
ADVAIR DISKUS 92 53 30 47
OXYCODONE-ACETAMINOPHEN 89 66 S2 31 43
CLONIDINE HCL 87 68 32 69
ATENOLOL 83 80 33 19
CLOPIDOGREL 80 73 34 44
DIGOXIN 79 64 35 92
OXYCODONE HCL-ACETAMINOPHEN 79 36 S2 35 73
PROAIR HFA 77 34 37 38
ALENDRONATE SODIUM 72 64 38 14
LANTUS 68 51 39 40
METOPROLOL TARTRATE 67 57 40 13
LABETALOL HCL 66 52 41 143
TAMSULOSIN HCL 65 63 42 24
JANUVIA 64 63 43 59
ALLOPURINOL 64 56 43 27
DIOVAN 64 40 43 42
FLUTICASONE PROPIONATE 60 45 46 23
PLAVIX 57 47 47 72
SPIRIVA 57 42 47 76
IBUPROFEN 57 35 47 60
CIPROFLOXACIN HCL 53 46 50 58
BENICAR 53 47 50 148
CLOTRIMAZOLE-BETAMETHASONE 51 42 52 171
ESCITALOPRAM OXALATE 51 49 52 98
FLUNISOLIDE 50 11 54 201
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 4, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.